With a population of over 220 Million, public health is one serious concern in Indonesia. Cancer in particular is a leading cause of deaths. Early diagnosis and effective treatment are keys for the control and management of this complex systemic disease, in which the research in Indonesia is still in its infancy.

As part of Lippo Medical and Health Program, that includes the Faculty of Medicine Pelita Harapan University, Siloam Hospitals and the Mochtar Riady Comprehensive Cancer Center (MRCCC), Mochtar Riady Institute for Nanotechnology (MRIN) is established in 2006 to support cancer research in Indonesia using both genomic and proteomic approaches.